BamSEC and AlphaSense Join Forces
Learn More

LENZ Therapeutics Inc.

NASDAQ: LENZ    
Share price (12/23/24): $31.30    
Market cap (12/23/24): $861 million

Material Contracts Filter

EX-10.1
from 10-Q 36 pages Stock Purchase Agreement
12/34/56
EX-10.21
from 8-K 30 pages Registration Rights Agreement
12/34/56
EX-10.16
from 8-K 4 pages Lenz Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.14
from 8-K 5 pages Lenz Therapeutics, Inc. Employment Letter March 21, 2024
12/34/56
EX-10.13
from 8-K 6 pages Lenz Therapeutics, Inc. Confirmatory Employment Letter March 21, 2024
12/34/56
EX-10.12
from 8-K 6 pages Lenz Therapeutics, Inc. Confirmatory Employment Letter March 21, 2024
12/34/56
EX-10.11
from 8-K 6 pages Lenz Therapeutics, Inc. Confirmatory Employment Letter March 21, 2024
12/34/56
EX-10.10
from 8-K 22 pages Lenz Therapeutics, Inc. 2024 Employee Stock Purchase Plan
12/34/56
EX-10.9
from 8-K 52 pages Lenz Therapeutics, Inc. 2024 Equity Incentive Plan
12/34/56
EX-10.8
from 8-K 6 pages Lock-Up Agreement
12/34/56
EX-10.7
from 8-K 15 pages Lenz Therapeutics, Inc. Support Agreement
12/34/56
EX-10.6
from 8-K 13 pages Graphite Bio, Inc. Support Agreement
12/34/56
EX-10.27
from 10-K 5 pages Graphite Bio, Inc. Compensation Recovery Policy Adopted as of November 14, 2023
12/34/56
EX-10.46
from S-4/A 29 pages License and Option Agreement
12/34/56
EX-10.45
from S-4/A 72 pages Asset Purchase Agreement by and Between Maro Bio Inc., a Delaware Corporation and Graphite Bio, Inc., a Delaware Corporation Dated as of August 1, 2023
12/34/56
EX-10.44
from S-4/A 14 pages Lenz Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.30
from S-4/A 63 pages License and Collaboration Agreement
12/34/56
EX-10.43
from S-4 9 pages Lenz Therapeutics, Inc. Employee Incentive Compensation Plan
12/34/56
EX-10.42
from S-4 4 pages Lenz Therapeutics, Inc. Outside Director Compensation Policy
12/34/56
EX-10.41
from S-4 12 pages Lenz Therapeutics, Inc. Executive Change in Control and Severance Policy
12/34/56